Limoneira Co (NASDAQ:LMNR - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $13.33 and traded as high as $13.92. Limoneira shares last traded at $13.76, with a volume of 80,849 shares trading hands.
Analysts Set New Price Targets
Several research analysts have recently commented on LMNR shares. Lake Street Capital decreased their target price on Limoneira from $19.00 to $18.00 and set a "buy" rating for the company in a research report on Wednesday, June 10th. HC Wainwright lowered Limoneira to a "buy" rating in a research report on Wednesday, June 10th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Limoneira in a research note on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Limoneira has an average rating of "Hold" and an average target price of $18.00.
View Our Latest Stock Report on LMNR
Limoneira Trading Down 0.1%
The firm has a market cap of $249.47 million, a P/E ratio of -6.04 and a beta of 0.30. The business's 50-day moving average is $13.52 and its two-hundred day moving average is $13.33. The company has a current ratio of 1.68, a quick ratio of 1.53 and a debt-to-equity ratio of 0.61.
Limoneira (NASDAQ:LMNR - Get Free Report) last issued its earnings results on Tuesday, June 9th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.08). The business had revenue of $23.93 million during the quarter, compared to the consensus estimate of $21.42 million. Limoneira had a negative return on equity of 13.94% and a negative net margin of 30.50%. As a group, analysts expect that Limoneira Co will post -0.47 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets lifted its stake in Limoneira by 64.8% in the second quarter. BNP Paribas Financial Markets now owns 1,699 shares of the company's stock valued at $27,000 after buying an additional 668 shares during the last quarter. Trust Co. of Vermont bought a new position in shares of Limoneira during the second quarter worth about $33,000. California State Teachers Retirement System increased its holdings in shares of Limoneira by 236.3% in the 2nd quarter. California State Teachers Retirement System now owns 3,033 shares of the company's stock worth $40,000 after acquiring an additional 2,131 shares during the period. Leonteq Securities AG increased its holdings in shares of Limoneira by 88.8% in the 1st quarter. Leonteq Securities AG now owns 3,386 shares of the company's stock worth $45,000 after acquiring an additional 1,593 shares during the period. Finally, MetLife Investment Management LLC lifted its position in Limoneira by 45.0% in the 4th quarter. MetLife Investment Management LLC now owns 9,765 shares of the company's stock valued at $123,000 after purchasing an additional 3,029 shares during the last quarter. 64.35% of the stock is currently owned by institutional investors.
Limoneira Company Profile
(
Get Free Report)
Limoneira Company NASDAQ: LMNR, founded in 1893 and based in Santa Paula, California, is a diversified agribusiness and real estate enterprise. As one of the oldest citrus producers in the United States, Limoneira has built a reputation for cultivating and marketing high-quality citrus fruits, avocados and specialty crops. The company's vertically integrated model encompasses farming, packing, processing and marketing activities designed to deliver fresh produce to domestic and international markets.
In its agricultural operations, Limoneira specializes in lemons, oranges and avocados, employing modern irrigation, harvesting and packing technologies to maintain consistent product quality and supply.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Limoneira, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Limoneira wasn't on the list.
While Limoneira currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.